Pediatric burns in Khuzestan Province, Iran

Hojjat Houshyarikhah1, Marzieh Shayestehfard, Hazhir Javaherizadeh

  • 1Abadan Faculty of Nursing, Ahvaz Jundishapur University of Medical Sciences, Abadan, Iran.

Insights

Scalding is the leading cause of pediatric burns in Khuzestan, Iran. Younger children and urban residents are most vulnerable, highlighting the need for targeted burn prevention education programs.

Area of Science:

  • Pediatric burn injuries
  • Injury epidemiology
  • Public health

Background:

  • Burn injuries represent a significant global pediatric health concern.
  • In Iran, pediatric burns are a notable public health issue requiring specific attention.
  • This study focuses on the epidemiology of pediatric burns in Khuzestan province.

Purpose of the Study:

  • To investigate the incidence and characteristics of pediatric burn injuries.
  • To analyze the etiological patterns and demographic factors associated with pediatric burns.
  • To identify risk factors for burn injuries in children in Khuzestan.

Main Methods:

  • A retrospective study design was employed, analyzing medical records of pediatric burn patients.
  • Data were collected from Taleghani Hospital, the sole burn treatment center in Khuzestan province.
  • The study encompassed 211 pediatric burn admissions between April 2006 and March 2007.

Main Results:

  • Scalding accounted for the vast majority (86.7%) of pediatric burns.
  • Younger children (mean age 2.95 years) were more prone to scald injuries compared to flame burns (mean age 4.28 years).
  • Children under four years old residing in urban areas were identified as the most vulnerable population group for burn injuries.

Conclusions:

  • Scalding is the predominant cause of pediatric burns in the studied region.
  • Young age (under 4 years) and urban residency are significant risk factors for pediatric burn incidents.
  • Implementing targeted educational burn prevention programs is crucial for mitigating burn injuries in Khuzestan's pediatric population.
Abstract

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...